Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017147820) DUAL-TARGETING DRUG CARRIER
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2017/147820 International Application No.: PCT/CN2016/075329
Publication Date: 08.09.2017 International Filing Date: 02.03.2016
IPC:
C07K 19/00 (2006.01) ,A61K 38/00 (2006.01) ,A61P 35/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
19
Hybrid peptides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
法玛科技顾问股份有限公司 FARMAR LICENSING CO., LTD. [CN/CN]; 中国台湾省台中市 西区公益路161号14楼之1 14F.-1, No.161, Kung Yi Rd., West Dist. Taichung City, 40360, TW
Inventors:
张正 CHANG, Cheng Allen; TW
蓝耿立 LAN, Keng-Li; TW
王信二 WANG, Hsin-Ell; TW
张顺福 CHANG, Shun-Fu; TW
李佳哲 LI, Jia-Je; TW
詹佩嘉 CHAN, Pei-Chia; TW
Agent:
北京元本知识产权代理事务所 BEIJING YUANBEN INTELLECTUAL PROPERTY LAW OFFICE; 中国北京市 海淀区花园路12号时代玉成403 403, Shidaiyucheng, No.12, Huayuan Road, Haidian District Beijing 100088, CN
Priority Data:
Title (EN) DUAL-TARGETING DRUG CARRIER
(FR) VECTEUR DE MÉDICAMENT À DOUBLE CIBLAGE
(ZH) 双重标靶药物载体
Abstract:
(EN) Provided is a dual-targeting drug carrier, comprising a first targeting molecule and a second targeting molecule. The targeting molecule comprises a peptide, an antibody, or a protein. The targeting molecule is able to bind to a specific receptor or a specific protein or glycoprotein. The target molecule can also conjugate with a radiation therapy material to form a conjugate.
(FR) L'invention concerne un vecteur de médicament à double ciblage comprenant une première molécule de ciblage et une seconde molécule de ciblage. La molécule de ciblage comprend un peptide, un anticorps ou une protéine. La molécule de ciblage est capable de se lier à un récepteur spécifique, ou à une protéine ou une glycoprotéine spécifique. La molécule cible peut également être conjuguée à un matériau de radiothérapie pour former un conjugué.
(ZH) 提供了一种双标靶药物载体,包括第一和第二标靶分子,其中标靶分子包括肽、抗体或蛋白质。所述标靶分子可结合至特定的受体、特异性蛋白或糖蛋白等,还可与放疗物质等共轭结合,形成共轭物。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)